Abstract
The role of plasminogen in preventing thrombosis requires activation by tissue plasminogen activator (t-PA) encoded by PLAT. While case–control associations have been pursued for common variants in PLAT, no disease-causing mutations have been reported. We describe a consanguineous family with two children who died shortly after birth due to complications related to severe hydranencephaly and diaphragmatic hernia. A combined exome/autozygome analysis was carried out with informed consent. We identified a homozygous null mutation in PLAT that abrogated t-PA level in patient cells. This is the first reported human knockout mutation of PLAT. The apparent association with hydranencephaly, diaphragmatic hernia and postnatal lethality requires further validation.
References
Alazami AM, Awad SM, Coskun S, Al-Hassan S, Hijazi H, Abdulwahab FM, Poizat C, Alkuraya FS (2015) TLE6 mutation causes the earliest known human embryonic lethality. Genome Biol 16:1–8
Alkuraya FS (2012) Discovery of rare homozygous mutations from studies of consanguineous pedigrees. Curr Protoc Hum Genet. doi:10.1002/0471142905.hg0612s75
Alkuraya FS (2013) The application of next-generation sequencing in the autozygosity mapping of human recessive diseases. Hum Genet 132:1197–1211
Carmeliet P, Schoonjans L, Kieckens L, Ream B, Degen J, Bronson R, De Vos R, van den Oord JJ, Collen D, Mulligan RC (1994) Physiological consequences of loss of plasminogen activator gene function in mice. Nature 368:419–424
Cecchetto G, Milanese L, Giordano R, Viero A, Suma V, Manara R (2013) Looking at the missing brain: hydranencephaly case series and literature review. Pediatr Neurol 48:152–158
Jannes J, Hamilton-Bruce MA, Pilotto L, Smith BJ, Mullighan CG, Bardy PG, Koblar SA (2004) Tissue plasminogen activator −7351C/T enhancer polymorphism is a risk factor for lacunar stroke. Stroke 35:1090–1094
Landenvall P, Johansson L, Jansson J-H, Jern S, Nilsson TK, Tjarnlund A, Jern C, Boman K (2002) Tissue-type plasminogen activator-7,351 C/T enhancer polymorphism is associated with a first myocardial infarction. Thromb Haemost Stuttg 87:105–109
Loscalzo J, Braunwald E (1988) Tissue plasminogen activator. N Engl J Med 319:925–931. doi:10.1056/NEJM198810063191407
Shamseldin HE, Tulbah M, Kurdi W, Nemer M, Alsahan N, Al Mardawi E, Khalifa O, Hashem A, Kurdi A, Babay Z (2015) Identification of embryonic lethal genes in humans by autozygosity mapping and exome sequencing in consanguineous families. Genome Biol 16:116
Acknowledgments
We thank the study family for their enthusiastic participation. We also thank the Genotyping and Sequencing Core Facilities at KFSHRC for their technical help. This work was supported in part by a KACST grant 13-BIO1113-20 (FSA).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Shamseldin, H.E., Aldeeri, A., Babay, Z. et al. A lethal phenotype associated with tissue plasminogen deficiency in humans. Hum Genet 135, 1209–1211 (2016). https://doi.org/10.1007/s00439-016-1711-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00439-016-1711-5